Retina-Vitreus, cilt.21, sa.3, ss.213-215, 2013 (Scopus)
We report the closure of a stage 2 macular hole with the release of vitreomacular traction in an eye with traction related stage 2 macular hole following the injection of 0.125 mg ocriplasmin. Intravitreal ocriplasmin therapy seems to be a promising method as an alternative to vitreoretinal surgery in eyes with symptomatic vitreous traction and macular holes.